| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |